Please use this identifier to cite or link to this item:
DC FieldValue
dc.titleIMI – Interventions myopia institute: Interventions for controlling myopia onset and progression report
dc.contributor.authorWildsoet, C.F.
dc.contributor.authorChia, A.
dc.contributor.authorCho, P.
dc.contributor.authorGuggenheim, J.A.
dc.contributor.authorPolling, J.R.
dc.contributor.authorRead, S.
dc.contributor.authorSankaridurg, P.
dc.contributor.authorSaw, S.-M.
dc.contributor.authorTrier, K.
dc.contributor.authorWalline, J.J.
dc.contributor.authorWu, P.-C.
dc.contributor.authorWolffsohn, J.S.
dc.identifier.citationWildsoet, C.F., Chia, A., Cho, P., Guggenheim, J.A., Polling, J.R., Read, S., Sankaridurg, P., Saw, S.-M., Trier, K., Walline, J.J., Wu, P.-C., Wolffsohn, J.S. (2019). IMI – Interventions myopia institute: Interventions for controlling myopia onset and progression report. Investigative Ophthalmology and Visual Science 60 : M106-M131. ScholarBank@NUS Repository.
dc.description.abstractMyopia has been predicted to affect approximately 50% of the world’s population based on trending myopia prevalence figures. Critical to minimizing the associated adverse visual consequences of complicating ocular pathologies are interventions to prevent or delay the onset of myopia, slow its progression, and to address the problem of mechanical instability of highly myopic eyes. Although treatment approaches are growing in number, evidence of treatment efficacy is variable. This article reviews research behind such interventions under four categories: optical, pharmacological, environmental (behavioral), and surgical. In summarizing the evidence of efficacy, results from randomized controlled trials have been given most weight, although such data are very limited for some treatments. The overall conclusion of this review is that there are multiple avenues for intervention worthy of exploration in all categories, although in the case of optical, pharmacological, and behavioral interventions for preventing or slowing progression of myopia, treatment efficacy at an individual level appears quite variable, with no one treatment being 100% effective in all patients. Further research is critical to understanding the factors underlying such variability and underlying mechanisms, to guide recommendations for combined treatments. There is also room for research into novel treatment options. © 2019 The Authors.
dc.publisherAssociation for Research in Vision and Ophthalmology Inc.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.sourceScopus OA2019
dc.subjectMyopia control
dc.contributor.departmentSAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
dc.description.sourcetitleInvestigative Ophthalmology and Visual Science
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1167_iovs_18-25958.pdf1.08 MBAdobe PDF



Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons